May 18, 2020
ImmuneFx Gene Therapy Could be a Game Changer for Cancer Treatment
Morphogenesis, a clinical-stage company that develops novel cell and gene therapies, based out of Tampa, recently got FDA approval to expand human clinical trials with an innovative cancer therapeutic. Grit Daily interviewed Morphogenesis CEO Dr. Patricia Lawman to get more information about this technology that could potentially be a game-changer in regard to cancer treatment. ImmuneFx is currently being studied in advanced Merkel cell carcinoma (MCC) and cutaneous squamous cell carcinoma (cSCC) patients.
Februrary 21, 2020
Tampa could be at the center of finding a cure for cancer
TAMPA, Fla. — Chances are you or somebody you know has battled cancer. But, did you know a potential treatment for the disease is being developed right here in the Tampa Bay area?
The company behind that promising work, Morphogenesis, announced it’s now expanding human trials of its vaccine called ImmuneFx.
“Yes, it’s very exciting,” said Patricia Lawman, CEO of Morphogenesis.
Februrary 20, 2020
Tampa company that developed cancer vaccine expanding human clinical trials
TAMPA, Fla. (WFLA) – The Tampa company that developed a cancer vaccine that targets a specific part of the disease in a patient is expanding its human clinical trials into late-stage cancers and enrolling new patients.
8 On Your Side first told you about Morphogenesis in August of 2019.
August 12, 2019
A small Tampa company is working on a big breakthrough: a cancer vaccine
By Justine Griffin; Tampa Bay Times
TAMPA — Tampa scientists Michael and Patricia Lawman imagine a day when cancer could be treated with a single needle prick and no debilitating side effects. And they see it coming sooner rather than later.
August 6, 2019
Tampa company testing cancer vaccine
FOX 13 Tampa Bay
TAMPA — A Tampa company says it is testing a vaccine for cancer. The vaccine does not prevent cancer. Instead, it explores a new way to help the body fight cancer cells.
August 2, 2019
Morphogenesis to expand clinical trials, physical footprint
By Veronica Brezina-Smith – Reporter, Tampa Bay Business Journal
The Tampa-based company develops gene and cell therapies to combat cancer.
August 27. 2018
Tampa company focused on cancer treatment launches first human clinical study
By Margie Manning – Finance Editor, Tampa Bay Business Journal
Morphogenesis Inc. is launching its first human clinical study for the treatment of skin cancer.
It’s an important benchmark for the Tampa company, which raised $16 million earlier this year in a Series A investment round led by entrepreneur and philanthropist Dr. Kiran Patel.
The Phase 1 study is “the biggest milestone so far” for Morphogenesis, said CEO Patricia Lawman…
May 9. 2018
Tampa Company To Begin Clinical Trials On Promising Cancer Therapy
WUSF Public Media-Health News Florida;
Morphogenesis, Inc. will begin the trials on six patients with an aggressive form of skin cancer at Moffitt Cancer Center this summer.
May 2 & 3, 2018
Latest Media Articles
Articles posted by both the Tampa Bay Business Journal and BioFlorida’s BioPulse Publication can be accessed below;
Tampa Bay Business Journal:
Why Kiran Patel is backing a Tampa company developing cancer treatments
New HQ puts Tampa immunotherapy company in Moffitt’s backyard
BioFlorida’s BioPulse Publication:
Morphogenesis, Inc Raises $16 Million To Advance Into Human Clinical Trials
July 28, 2016
Greenville Online-Part of the USA Today Network: Cancer vaccine used on dogs may one day help their owners
Liv Osby, losby@gannett.com
Greenville, North Carolina. Ingrid and Ben Herrmann-Holmes love their dogs and tend to adopt older ones, like their three elderly basset hounds — one who needs a wheelchair. So when their 13-year-old Blue Tick Coonhound began limping on his left front leg, they took him to the vet right away. The news wasn’t good.
June 29, 2016
Coverage of the Morphogenesis hosting of the Vice President’s Cancer Moonshot Summit
Live coverage of the event by Dr. Joette Giovinco from Fox 13 News can be viewed through Facebook. In addition, coverage by Fox 13 News, NBC News Channel 8 and CBS 10 News can be viewed by clicking on the images below;
